Efficacy and Safety Study of Cetuximab or Cetuximab Plus Docetaxel to Treat Prostate Cancer Before Prostatectomy
Status:
Terminated
Trial end date:
2008-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to differentiate between the administrations of Cetuximab alone
vs. Cetuximab plus Docetaxel in the treatment of non-metastatic prostate cancer before the
surgical removal of the prostate.
Phase:
Phase 2
Details
Lead Sponsor:
The Methodist Hospital Research Institute The Methodist Hospital System
Collaborators:
Bristol-Myers Squibb Eli Lilly and Company ImClone LLC